{"id":17974,"date":"2017-09-07T20:05:42","date_gmt":"2017-09-07T18:05:42","guid":{"rendered":"http:\/\/localhost:8888\/TG180623\/?p=17974"},"modified":"2025-11-12T16:36:10","modified_gmt":"2025-11-12T15:36:10","slug":"a-phase-ib-trial-of-jx-594-pexa-vec-a-targeted-multimechanistic-oncolytic-vaccinia-virus-in-combination-with-low-dose-cyclophosphamide-in-patients-with-advanced-solid-tumors-is-l","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/a-phase-ib-trial-of-jx-594-pexa-vec-a-targeted-multimechanistic-oncolytic-vaccinia-virus-in-combination-with-low-dose-cyclophosphamide-in-patients-with-advanced-solid-tumors-is-l\/","title":{"rendered":"A phase Ib trial of JX-594 (Pexa-Vec), a targeted multimechanistic oncolytic vaccinia virus, in combination with low-dose cyclophosphamide in patients with advanced solid tumors"},"content":{"rendered":"<p><a href=\"https:\/\/cslide.ctimeetingtech.com\/library\/esmo\/browse\/search\/2mKQ\"><\/a><br \/>\nMaud Toulmonde, et al.<br \/>\nESMO 2017, September 11, 2017, 13:15 &#8211; 14:15, Hall 8<br \/>\nDownload the poster <a href=\"https:\/\/cslide.ctimeetingtech.com\/library\/esmo\/browse\/search\/2mKQ\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>here<\/strong><\/a><br \/>\n<em>Poster Presentation<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Maud Toulmonde, et al. ESMO 2017, September 11, 2017, 13:15 &#8211; 14:15, Hall 8 Download the poster here Poster Presentation<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[181,130,14,5],"tags":[33,34],"class_list":["post-17974","post","type-post","status-publish","format-standard","hentry","category-other-fr","category-130","category-pexa-vec-fr","category-publication-fr","tag-oncolytic-virus","tag-poster-presentation","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"Maud Toulmonde, et al. ESMO 2017, September 11, 2017, 13:15 &#8211; 14:15, Hall 8 Download the poster here Poster Presentation","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/17974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=17974"}],"version-history":[{"count":1,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/17974\/revisions"}],"predecessor-version":[{"id":38796,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/17974\/revisions\/38796"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=17974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=17974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=17974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}